4//SEC Filing
Kewalramani Reshma 4
Accession 0000875320-24-000160
CIK 0000875320other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 4:08 PM ET
Size
8.2 KB
Accession
0000875320-24-000160
Insider Transaction Report
Form 4
Kewalramani Reshma
DirectorCEO & President
Transactions
- Exercise/Conversion
Common Stock
2024-05-24$187.53/sh+1,565$293,484→ 122,939 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-24−1,565→ 0 totalExercise: $187.53Exp: 2029-02-05→ Common Stock (1,565 underlying) - Sale
Common Stock
2024-05-24$457.00/sh−1,565$715,205→ 121,374 total
Footnotes (2)
- [F1]Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1, which was entered into on 02/07/2024.
- [F2]Fully vested.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001735944
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 4:08 PM ET
- Size
- 8.2 KB